BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36592862)

  • 1. Modeling of a Novel Patient-Based MYO5B Point Mutation Reveals Insights Into MVID Pathogenesis.
    Burman A; Momoh M; Sampson L; Skelton J; Roland JT; Ramos C; Krystofiak E; Acra S; Goldenring JR; Kaji I
    Cell Mol Gastroenterol Hepatol; 2023; 15(4):1022-1026. PubMed ID: 36592862
    [No Abstract]   [Full Text] [Related]  

  • 2. MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarity.
    Müller T; Hess MW; Schiefermeier N; Pfaller K; Ebner HL; Heinz-Erian P; Ponstingl H; Partsch J; Röllinghoff B; Köhler H; Berger T; Lenhartz H; Schlenck B; Houwen RJ; Taylor CJ; Zoller H; Lechner S; Goulet O; Utermann G; Ruemmele FM; Huber LA; Janecke AR
    Nat Genet; 2008 Oct; 40(10):1163-5. PubMed ID: 18724368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview and online registry of microvillus inclusion disease patients and their MYO5B mutations.
    van der Velde KJ; Dhekne HS; Swertz MA; Sirigu S; Ropars V; Vinke PC; Rengaw T; van den Akker PC; Rings EH; Houdusse A; van Ijzendoorn SC
    Hum Mutat; 2013 Dec; 34(12):1597-605. PubMed ID: 24014347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myosin Vb uncoupling from RAB8A and RAB11A elicits microvillus inclusion disease.
    Knowles BC; Roland JT; Krishnan M; Tyska MJ; Lapierre LA; Dickman PS; Goldenring JR; Shub MD
    J Clin Invest; 2014 Jul; 124(7):2947-62. PubMed ID: 24892806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvillus inclusion disease: loss of Myosin vb disrupts intracellular traffic and cell polarity.
    Thoeni CE; Vogel GF; Tancevski I; Geley S; Lechner S; Pfaller K; Hess MW; Müller T; Janecke AR; Avitzur Y; Muise A; Cutz E; Huber LA
    Traffic; 2014 Jan; 15(1):22-42. PubMed ID: 24138727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myosin 5b loss of function leads to defects in polarized signaling: implication for microvillus inclusion disease pathogenesis and treatment.
    Kravtsov D; Mashukova A; Forteza R; Rodriguez MM; Ameen NA; Salas PJ
    Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G992-G1001. PubMed ID: 25258405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editing Myosin VB Gene to Create Porcine Model of Microvillus Inclusion Disease, With Microvillus-Lined Inclusions and Alterations in Sodium Transporters.
    Engevik AC; Coutts AW; Kaji I; Rodriguez P; Ongaratto F; Saqui-Salces M; Medida RL; Meyer AR; Kolobova E; Engevik MA; Williams JA; Shub MD; Carlson DF; Melkamu T; Goldenring JR
    Gastroenterology; 2020 Jun; 158(8):2236-2249.e9. PubMed ID: 32112796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease.
    Girard M; Lacaille F; Verkarre V; Mategot R; Feldmann G; Grodet A; Sauvat F; Irtan S; Davit-Spraul A; Jacquemin E; Ruemmele F; Rainteau D; Goulet O; Colomb V; Chardot C; Henrion-Caude A; Debray D
    Hepatology; 2014 Jul; 60(1):301-10. PubMed ID: 24375397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of intestinal ion transport defects in microvillus inclusion disease.
    Kravtsov DV; Ahsan MK; Kumari V; van Ijzendoorn SC; Reyes-Mugica M; Kumar A; Gujral T; Dudeja PK; Ameen NA
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G142-55. PubMed ID: 27229121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYO5B mutations in patients with microvillus inclusion disease presenting with transient renal Fanconi syndrome.
    Golachowska MR; van Dael CM; Keuning H; Karrenbeld A; Hoekstra D; Gijsbers CF; Benninga MA; Rings EH; van Ijzendoorn SC
    J Pediatr Gastroenterol Nutr; 2012 Apr; 54(4):491-8. PubMed ID: 22441677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss-of-function of MYO5B is the main cause of microvillus inclusion disease: 15 novel mutations and a CaCo-2 RNAi cell model.
    Ruemmele FM; Müller T; Schiefermeier N; Ebner HL; Lechner S; Pfaller K; Thöni CE; Goulet O; Lacaille F; Schmitz J; Colomb V; Sauvat F; Revillon Y; Canioni D; Brousse N; de Saint-Basile G; Lefebvre J; Heinz-Erian P; Enninger A; Utermann G; Hess MW; Janecke AR; Huber LA
    Hum Mutat; 2010 May; 31(5):544-51. PubMed ID: 20186687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of mutations in the myosin Vb gene associated with microvillus inclusion disease.
    Szperl AM; Golachowska MR; Bruinenberg M; Prekeris R; Thunnissen AM; Karrenbeld A; Dijkstra G; Hoekstra D; Mercer D; Ksiazyk J; Wijmenga C; Wapenaar MC; Rings EH; van IJzendoorn SC
    J Pediatr Gastroenterol Nutr; 2011 Mar; 52(3):307-13. PubMed ID: 21206382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel
    Hassan K; Robay A; Al-Maraghi A; Nimeri N; Azzam AB; Al Shakaki A; Hamid E; Crystal RG; Fakhro KA
    Cold Spring Harb Mol Case Stud; 2022 Feb; 8(2):. PubMed ID: 34815247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apical Membrane Alterations in Non-intestinal Organs in Microvillus Inclusion Disease.
    Schlegel C; Weis VG; Knowles BC; Lapierre LA; Martin MG; Dickman P; Goldenring JR; Shub MD
    Dig Dis Sci; 2018 Feb; 63(2):356-365. PubMed ID: 29218485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inducible mouse model for microvillus inclusion disease reveals a role for myosin Vb in apical and basolateral trafficking.
    Schneeberger K; Vogel GF; Teunissen H; van Ommen DD; Begthel H; El Bouazzaoui L; van Vugt AH; Beekman JM; Klumperman J; Müller T; Janecke A; Gerner P; Huber LA; Hess MW; Clevers H; van Es JH; Nieuwenhuis EE; Middendorp S
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12408-13. PubMed ID: 26392529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of MYO5B Leads to Reductions in Na
    Engevik AC; Kaji I; Engevik MA; Meyer AR; Weis VG; Goldstein A; Hess MW; Müller T; Koepsell H; Dudeja PK; Tyska M; Huber LA; Shub MD; Ameen N; Goldenring JR
    Gastroenterology; 2018 Dec; 155(6):1883-1897.e10. PubMed ID: 30144427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease.
    Kalashyan M; Raghunathan K; Oller H; Bayer MT; Jimenez L; Roland JT; Kolobova E; Hagen SJ; Goldsmith JD; Shub MD; Goldenring JR; Kaji I; Thiagarajah JR
    J Clin Invest; 2023 Oct; 133(20):. PubMed ID: 37643022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The zebrafish goosepimples/myosin Vb mutant exhibits cellular attributes of human microvillus inclusion disease.
    Sidhaye J; Pinto CS; Dharap S; Jacob T; Bhargava S; Sonawane M
    Mech Dev; 2016 Nov; 142():62-74. PubMed ID: 27497746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYO5B-associated diseases: Novel liver-related variants and genotype-phenotype correlation.
    Wang L; Qiu YL; Xu HM; Zhu J; Li SJ; OuYang WX; Yang YF; Lu Y; Xie XB; Xing QH; Wang JS
    Liver Int; 2022 Feb; 42(2):402-411. PubMed ID: 34811877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defects in myosin VB are associated with a spectrum of previously undiagnosed low γ-glutamyltransferase cholestasis.
    Qiu YL; Gong JY; Feng JY; Wang RX; Han J; Liu T; Lu Y; Li LT; Zhang MH; Sheps JA; Wang NL; Yan YY; Li JQ; Chen L; Borchers CH; Sipos B; Knisely AS; Ling V; Xing QH; Wang JS
    Hepatology; 2017 May; 65(5):1655-1669. PubMed ID: 28027573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.